{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:25:06Z","timestamp":1762917906237,"version":"3.41.0"},"reference-count":38,"publisher":"Radcliffe Medical Media Ltd","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"abstract":"<jats:p>Arrhythmogenic inflammatory cardiomyopathy is a recent clinical description of a subgroup of patients with non-ischaemic cardiomyopathy who are referred to electrophysiologists for evaluation and management of ventricular arrhythmias and are found to have evidence of active cardiac inflammation. The identification of these patients is key, since the aetiology of their arrhythmic burden is likely both related to scar-mediated and direct inflammatory mechanisms, which may have different treatment approaches. Evaluation of these patients starts with a full clinical history and physical examination along with echocardiography, as with most patients with cardiomyopathy, however, additional imaging with fluorodeoxyglucose PET-CT and cardiac MRI is crucial. Medical treatment is aimed at targeting traditional neurohumeral mediators to achieve recovery of ejection fraction, in addition to immunosuppressant medication to directly treat inflammation. While medical treatment alone is successful in many patients, some will require further invasive management with electrophysiologic study and radiofrequency catheter ablation.<\/jats:p>","DOI":"10.15420\/aer.2018.26.2","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T00:12:12Z","timestamp":1537056732000},"page":"181","source":"Crossref","is-referenced-by-count":8,"title":["Arrhythmogenic Inflammatory Cardiomyopathy: A Review"],"prefix":"10.15420","volume":"7","author":[{"given":"Brenton S","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason S","family":"Bradfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Ajijola OA, Tung R, Shivkumar, K. Ventricular tachycardia in ischemic heart disease substrates. Indian Heart J 2014; 66(Suppl 1):S24\u221234.","DOI":"10.1016\/j.ihj.2013.12.039"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Dinov B, Fiedler L, Schonbauer R, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation 2014;129:728\u221236.","DOI":"10.1161\/CIRCULATIONAHA.113.003063"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Sacher F, Tedrow UB, Field ME, et al. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol 2008;1):153\u221261.","DOI":"10.1161\/CIRCEP.108.769471"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Wu AH. Management of patients with non-ischaemic cardiomyopathy. Heart 2007;93:403\u22128. h","DOI":"10.1136\/hrt.2005.085761"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Tung R, Bauer B, Schelbert H, et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. Heart Rhythm 2015;12:2488\u221298.","DOI":"10.1016\/j.hrthm.2015.08.014"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538\u221243.","DOI":"10.1093\/eurheartj\/ehi180"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Lipshultz, SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647\u221255.","DOI":"10.1056\/NEJMoa021715"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Sekhri V, Sanal S, Delorenzo LJ, et al. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci 2011;7:546\u221254.","DOI":"10.5114\/aoms.2011.24118"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 2012;59:779\u221292.","DOI":"10.1016\/j.jacc.2011.09.074"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Donoso Mantke O, Meyer R, Prosch S, et al. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool. J Heart Lung Transplant 2005;24:1632\u22128.","DOI":"10.1016\/j.healun.2004.12.116"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Haddad F, Berry G, Doyle RL, et al. Active bacterial myocarditis J Heart Lung Transplant 2007;26:745\u22129.","DOI":"10.1016\/j.healun.2007.04.010"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Klein RM, Vester EG, Brehm MU, et al. Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol 2000;89(Suppl 3):24\u221235 [in German].","DOI":"10.1007\/s003920070080"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Mueller KA, Heck C, Heinzmann D, et al. Comparison of ventricular inducibility with late gadolinium enhancement and myocardial inflammation in endomyocardial biopsy in patients with dilated cardiomyopathy. PLoS One 2016;11:e0167616.","DOI":"10.1371\/journal.pone.0167616"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Scott PA, Rosengarten JA, Curzen NP, Morgan JM. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail 2013;15:1019\u221227.","DOI":"10.1093\/eurjhf\/hft053"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Blankstein R, Osborne M, Masanao, N, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014;63:329\u221236.","DOI":"10.1016\/j.jacc.2013.09.022"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Shah BN, De Villa M, Khattar RS, Senior R. Imaging cardiac sarcoidosis: the incremental benefit of speckle tracking echocardiography. Echocardiography 2013;30:E213\u22124.","DOI":"10.1111\/echo.12208"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53:1475\u221287.","DOI":"10.1016\/j.jacc.2009.02.007"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Olimulder MA, van Es J and Galjee MA. The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy. Neth Heart J 2009;17:481\u22126.","DOI":"10.1007\/BF03086308"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005;184:249\u221254.","DOI":"10.2214\/ajr.184.1.01840249"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Montant P, Sigovan M, Revel D, Douek P. MR imaging assessment of myocardial edema with T2 mapping. Diagn Interv Imaging 2015;96:885\u221290.","DOI":"10.1016\/j.diii.2014.07.008"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21. Akdis D, Brunckhorst C, Duru F, Saguner AM. Arrhythmogenic cardiomyopathy: electrical and structural phenotypes. Arrhythm Electrophysiol Rev 2016;5:90\u2212101.","DOI":"10.15420\/AER.2016.4.3"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Tandri H, Castillo E, Ferrari VA, et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006;48:2277\u221284.","DOI":"10.1016\/j.jacc.2006.07.051"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012; 53:241\u22128.","DOI":"10.2967\/jnumed.111.090662"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Yamaguchi H, Hasegawa S, Yoshioka J, et al. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy. Ann Nucl Med 2000;14:33\u22128.","DOI":"10.1007\/BF02990476"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Shelke AB, Aurangabadka HU, Bradfield JS, et al. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis. Int J Cardiol 2016;228:717\u2212722.","DOI":"10.1016\/j.ijcard.2016.11.142"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Yuan Z, Shioji K, Kihara Y, et al. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. Am J Physiol Heart Circ Physiol 2004;286:H83\u221290.","DOI":"10.1152\/ajpheart.00536.2003"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Exner DV, Reiffel JA, Epstein AE, et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 1999;34:325\u221233.","DOI":"10.1016\/S0735-1097(99)00234-X"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Godsel LM, Leon JS, Wang K, et al. Captopril prevents experimental autoimmune myocarditis. J Immunol 2003;171:346\u221252.","DOI":"10.4049\/jimmunol.171.1.346"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Bahk TJ, Daniels MD, Leon JS, et al. Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis. Int J Cardiol 2008;125:85\u221293.","DOI":"10.1016\/j.ijcard.2007.04.062"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989;321:1061\u22128.","DOI":"10.1056\/NEJM198910193211601"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Maisch B, Hufnagel G, Schonian U, Hengstenberg C. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). Eur Heart J 1995;16(Suppl O): 173\u22125.","DOI":"10.1093\/eurheartj\/16.suppl_O.173"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269\u221275.","DOI":"10.1056\/NEJM199508033330501"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Frustaci A, Russo MA, and Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30:1995\u22122002.","DOI":"10.1093\/eurheartj\/ehp249"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933\u221240.","DOI":"10.1056\/NEJM199612263352601"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877\u221283.","DOI":"10.1056\/NEJMoa013474"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225\u221237.","DOI":"10.1056\/NEJMoa043399"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Kober L, Thune JJ, Nielsen JJ, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016;375:1221\u221230.","DOI":"10.1056\/NEJMoa1608029"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Kumar S, Barbhaiya C, Nagashima K, et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 2015;8:87\u221293.","DOI":"10.1161\/CIRCEP.114.002145"}],"container-title":["Arrhythmia &amp; Electrophysiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aerjournal.com\/articles\/arrhythmogenic-inflammatory-cardiomyopathy-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T12:48:37Z","timestamp":1662036517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerjournal.com\/articles\/arrhythmogenic-inflammatory-cardiomyopathy-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["aer.2018.26.2"],"URL":"https:\/\/doi.org\/10.15420\/aer.2018.26.2","relation":{},"ISSN":["2050-3377"],"issn-type":[{"type":"print","value":"2050-3377"}],"subject":[],"published":{"date-parts":[[2018]]}}}